Von Recklinghausen
Neurofibromatosis type 1 (NF1) was first described in 1882 by the German pathologist Von Recklinghausen. Neurofibromatosis type 2 (NF2) was first described in 1820 by the Scottish surgeon JH Wishart.
The person credited with the discovery of neurofibromatosis is Fredich Daniel van Recklinghausen. He released an article identifying it back in 1882.
Clinical genetic testing can confirm the presence of a mutation in the neurofibromatosis type 1 (NF1) gene. Prenatal testing for NF1 mutations is also possible using amniocentesis or chorionic villus sampling procedures. Genetic testing for neurofibromatosis type 2 (NF2) mutations is sometimes available but is accurate only in about 65 percent of those individuals tested.
There are no available treatments for the disorders which underlie either type of neurofibromatosis. To some extent, the symptoms of NF-1 and NF-2 can be treated individually. Skin tumors can be surgically removed. Some brain tumors.
Huntington's Disease
Boris Kin Lin has written: 'Characterization of the neurofibromatosis type 1 gene product and its interaction with RAS'
http://en.wikipedia.org/wiki/Neurofibromatosis
Multiple Endocrine Neoplasia, type 2A (MEN2A), Multiple Endocrine Neoplasia, type 2B (MEN2B), von Hippel-Lindau disease (VHL) and Neurofibromatosis type 1 (NF1).
The cause of neurofibromatosis type 1 is a genetic mutation in the NF1 gene. This gene is the one that produces a protein that helps regulate the growth of nerve tissue.
He discovered genes causing cystic fibrosis, neurofibromatosis, and Huntington Chorea. (i would spell check this answer) please look to further references.
Neurofibromatosis is usually diagnosed when the patient has 10 or more cafe-au-lait spots.
Yes, in Dallas, Texas it is called the NSG (Neurofibromatosis Support Group)